InvestorsHub on MSN

AstraZeneca shares slip after HSBC cuts rating following Wainua setback (AZN)

HSBC Downgrades AstraZeneca to Hold AstraZeneca (NASDAQ:AZN) shares moved lower on Monday after HSBC downgraded the ...
CNBC

HSBC's Rajesh Kumar on Novo Nordisk: We want to see management team execute turnaround strategy

Rajesh Kumar, HSBC Sr. health care analyst, joins CNBC's 'Money Movers' to discuss his reaction to a board shakeup at Novo Nordisk. Got a confidential news tip? We want to hear from you. Sign up for ...

AstraZeneca (AZN) was downgraded to a Hold Rating at HSBC

In a report released today, Rajesh Kumar from HSBC downgraded AstraZeneca to a Hold, with a price target of p13,750.00. TipRanks Welcomes a New ETF – NYSE:RANK. TipRanks has ent ...
Yahoo Finance

HSBC highlights one pharma stock to buy and one to sell for 2026

Investing.com -- HSBC shifted its ratings across U.S. large-cap pharmaceuticals in a note on Wednesday, led by Rajesh Kumar, upgrading AbbVie to Buy while cutting Biogen to Reduce, as the bank ...

Pfizer's growth story faces a wait as pipeline and leadership doubts mount

HSBC downgraded Pfizer Inc. PFE on Monday, citing that the company’s near-term re-rating prospects have weakened despite its ...